Marble Wealth LLC Invests $957,000 in Intuitive Surgical, Inc. $ISRG

Marble Wealth LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,689 shares of the medical equipment provider’s stock, valued at approximately $957,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Rational Advisors Inc. lifted its position in Intuitive Surgical by 46.7% during the fourth quarter. Rational Advisors Inc. now owns 1,665 shares of the medical equipment provider’s stock valued at $943,000 after purchasing an additional 530 shares during the period. Harfst & Associates Inc. lifted its position in Intuitive Surgical by 1.8% during the fourth quarter. Harfst & Associates Inc. now owns 3,167 shares of the medical equipment provider’s stock valued at $1,794,000 after purchasing an additional 56 shares during the period. Westpac Banking Corp lifted its position in Intuitive Surgical by 6.6% during the fourth quarter. Westpac Banking Corp now owns 4,653 shares of the medical equipment provider’s stock valued at $2,635,000 after purchasing an additional 287 shares during the period. Rice Partnership LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at $207,000. Finally, Kesler Norman & Wride LLC lifted its position in Intuitive Surgical by 97.5% during the fourth quarter. Kesler Norman & Wride LLC now owns 2,111 shares of the medical equipment provider’s stock valued at $1,196,000 after purchasing an additional 1,042 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday. Jefferies Financial Group decreased their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. HSBC decreased their target price on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Finally, The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $573.63.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical (ISRG) to $366 from $440 and kept a sell rating, reinforcing concerns that the stock may have further downside from current levels. MarketScreener article
• Negative Sentiment: Company SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 plan, a transaction that can still weigh on sentiment because it reduces insider ownership and may signal caution to some investors.
• Neutral Sentiment: Several articles highlighted that ISRG is a highly watched and frequently traded name, but these pieces were mostly informational and did not present a new catalyst. Zacks article
• Neutral Sentiment: Analysts and commentary also pointed to Intuitive Surgical’s AI-driven digital roadmap and connected da Vinci ecosystem as a potential long-term growth driver, but that story appears to be offset today by valuation and rating concerns. Yahoo Finance article

Intuitive Surgical Stock Performance

ISRG opened at $402.30 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The company has a fifty day moving average of $452.19 and a two-hundred day moving average of $504.81. The stock has a market capitalization of $142.48 billion, a price-to-earnings ratio of 48.76, a PEG ratio of 3.29 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter in the previous year, the company earned $1.81 earnings per share. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 648 shares of Intuitive Surgical stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $495.20, for a total value of $320,889.60. Following the completion of the transaction, the senior vice president owned 2,258 shares of the company’s stock, valued at approximately $1,118,161.60. The trade was a 22.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 8,096 shares of company stock valued at $3,545,294 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.